Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Lone Pine’s Steve Mandel’s Performance Slips in 3rd Quarter

Steve Mandel started Lone Pine Capital in 1997 and has since grown it to one of the largest in the industry, but even the mighty fall. More frequently than not, they fall louder and longer than any others. Now Mandel has joined the ranks of those hedge fund managers with less than impressive performance reports CNBC.


Steve Mandel Says ‘It Was a Rough Quarter’

Lone Pine’s Steve Mandel has not had a good third quarter. “It was a rough quarter” Mandel said. He described the fund’s performance as “quite respectable until the last week of September.” “Stocks globally are currently cheaper, based on consensus earnings estimates, than at any time in our 14-year history.” Mandel “blamed currently higher risk premiums and lower earnings multiples on a lack of political leadership, coupled with high levels of developed world government debt.”

Lone Pine’s Third Quarter Performance

“Lone Pine’s $8.7 billion Lone Cascade family of hedge funds took a beating in the third quarter,” reports CNBC, “with Lone Cascade down 14.3 percent, Lone Cypress down 9.8 percent, Lone Kauri down 8 percent and Lone Dragon Pine down 25.1 percent vs. the S&P 500, which was down 13.9 percent.” It said, “Year-to-date the Lone Cascade fund is down 9.2 percent, Cypress is down 4.2 percent, Kauri down 3.8 percent and Lone Dragon Pine down 25.3 percent versus the S&P 500, which was down 8.7 percent.”

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!